BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Samandari M, Julia MG, Rice A, Chronopoulos A, del Rio Hernandez AE. Liquid biopsies for management of pancreatic cancer. Translational Research 2018;201:98-127. [DOI: 10.1016/j.trsl.2018.07.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Vaziri N, Shariati L, Javanmard SH. Leukemia inhibitory factor: A main controller of breast cancer. J Biosci 2020;45. [DOI: 10.1007/s12038-020-00115-5] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lunelli L, Caradonna F, Potrich C, Piotto C, Bettotti P, Vanzetti L, Pederzolli C, Guella G. A new silanizing agent tailored to surface bio-functionalization. Colloids Surf B Biointerfaces 2019;181:166-73. [PMID: 31132608 DOI: 10.1016/j.colsurfb.2019.05.034] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
3 Zhang P, Zhou H, Lu K, Wang Y, Feng T. Circulating tumor cells in the clinical cancer diagnosis. Clin Transl Oncol 2020;22:279-82. [DOI: 10.1007/s12094-019-02139-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Nagai M, Sho M, Akahori T, Nakagawa K, Nakamura K. Application of liquid biopsy for surgical management of pancreatic cancer. Ann Gastroenterol Surg 2020;4:216-23. [PMID: 32490335 DOI: 10.1002/ags3.12317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Perri G, Prakash LR, Katz MHG. Response to Preoperative Therapy in Localized Pancreatic Cancer. Front Oncol 2020;10:516. [PMID: 32351893 DOI: 10.3389/fonc.2020.00516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Alawsi T, Al‐bawi Z. A review of smartphone point‐of‐care adapter design. Engineering Reports 2019;1. [DOI: 10.1002/eng2.12039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
7 Wang K, He H. Pancreatic Tumor Microenvironment. Adv Exp Med Biol 2020;1296:243-57. [PMID: 34185297 DOI: 10.1007/978-3-030-59038-3_15] [Reference Citation Analysis]
8 Descamps L, Le Roy D, Deman AL. Microfluidic-Based Technologies for CTC Isolation: A Review of 10 Years of Intense Efforts towards Liquid Biopsy. Int J Mol Sci 2022;23:1981. [PMID: 35216097 DOI: 10.3390/ijms23041981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Søreide K, Primavesi F, Labori KJ, Watson MM, Stättner S. Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy. Eur Surg 2019;51:126-34. [DOI: 10.1007/s10353-019-0575-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
10 Long D, Tian XD, Yang Y. Emerging Role of Exosomal-Derived Long Noncoding RNAs in Human PDAC. Visc Med 2022;38:30-6. [DOI: 10.1159/000520947] [Reference Citation Analysis]
11 Liu P, Kong L, Jin H, Wu Y, Tan X, Song B. Differential secretome of pancreatic cancer cells in serum-containing conditioned medium reveals CCT8 as a new biomarker of pancreatic cancer invasion and metastasis. Cancer Cell Int 2019;19:262. [PMID: 31632196 DOI: 10.1186/s12935-019-0980-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yin L, Miao Y, Yu J. Advances of pathological complete response after neoadjuvant therapy for pancreatic cancer. Journal of Pancreatology 2019;2:11-5. [DOI: 10.1097/jp9.0000000000000009] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Buscail E, Maulat C, Muscari F, Chiche L, Cordelier P, Dabernat S, Alix-Panabières C, Buscail L. Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2019;11:E852. [PMID: 31248203 DOI: 10.3390/cancers11060852] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 8.7] [Reference Citation Analysis]
14 Fang Z, Meng Q, Zhang B, Shi S, Liu J, Liang C, Hua J, Yu X, Xu J, Wang W. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis. Aging (Albany NY) 2020;13:2031-48. [PMID: 33318293 DOI: 10.18632/aging.202199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang Y, Wei Y, Liu P, Zhang X, Xu Z, Tan X, Chen M, Wang J. ICP-MS and Photothermal Dual-Readout Assay for Ultrasensitive and Point-of-Care Detection of Pancreatic Cancer Exosomes. Anal Chem 2021;93:11540-6. [PMID: 34369746 DOI: 10.1021/acs.analchem.1c02004] [Reference Citation Analysis]
16 González-Borja I, Viúdez A, Goñi S, Santamaria E, Carrasco-García E, Pérez-Sanz J, Hernández-García I, Sala-Elarre P, Arrazubi V, Oyaga-Iriarte E, Zárate R, Arévalo S, Sayar O, Vera R, Fernández-Irigoyen J. Omics Approaches in Pancreatic Adenocarcinoma. Cancers (Basel) 2019;11:E1052. [PMID: 31349663 DOI: 10.3390/cancers11081052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Grunvald MW, Jacobson RA, Kuzel TM, Pappas SG, Masood A. Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer. Int J Mol Sci. 2020;21:7651. [PMID: 33081107 DOI: 10.3390/ijms21207651] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Jiang D, Yuan X, Ni J, Shen L, Cai M, Xu L. Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study. Can J Gastroenterol Hepatol 2021;2021:8882129. [PMID: 34222137 DOI: 10.1155/2021/8882129] [Reference Citation Analysis]
19 Lunelli L, Barbaresco F, Scordo G, Potrich C, Vanzetti L, Marasso SL, Cocuzza M, Pirri CF, Pederzolli C. PDMS-Based Microdevices for the Capture of MicroRNA Biomarkers. Applied Sciences 2020;10:3867. [DOI: 10.3390/app10113867] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Uesato Y, Sasahira N, Ozaka M, Sasaki T, Takatsuki M, Zembutsu H. Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis. PLoS One 2020;15:e0235623. [PMID: 32614932 DOI: 10.1371/journal.pone.0235623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Yang J, Xu R, Wang C, Qiu J, Ren B, You L. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Commun (Lond) 2021. [PMID: 34331845 DOI: 10.1002/cac2.12204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Samandari M, Alipanah F, Haghjooy Javanmard S, Sanati-nezhad A. One-step wettability patterning of PDMS microchannels for generation of monodisperse alginate microbeads by in Situ external gelation in double emulsion microdroplets. Sensors and Actuators B: Chemical 2019;291:418-25. [DOI: 10.1016/j.snb.2019.04.100] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 6.7] [Reference Citation Analysis]
23 Kobayashi T, Honda K. Trends in biomarker discoveries for the early detection and risk stratification of pancreatic cancer using omics studies. Expert Rev Mol Diagn 2019;19:651-4. [PMID: 31298060 DOI: 10.1080/14737159.2019.1643718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sadighbayan D, Sadighbayan K, Khosroushahi AY, Hasanzadeh M. Recent advances on the DNA-based electrochemical biosensing of cancer biomarkers: Analytical approach. TrAC Trends in Analytical Chemistry 2019;119:115609. [DOI: 10.1016/j.trac.2019.07.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
25 Rice A, Del Rio Hernandez A. The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA. Front Oncol 2019;9:952. [PMID: 31608239 DOI: 10.3389/fonc.2019.00952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Peng C, Wang J, Gao W, Huang L, Liu Y, Li X, Li Z, Yu X. Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer. Int J Med Sci 2021;18:660-71. [PMID: 33437201 DOI: 10.7150/ijms.52706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Rodríguez-Casanova A, Bao-Caamano A, Lago-Lestón RM, Brozos-Vázquez E, Costa-Fraga N, Ferreirós-Vidal I, Abdulkader I, Vidal-Insua Y, Rivera FV, Candamio Folgar S, López-López R, Muinelo-Romay L, Diaz-Lagares A. Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer. J Clin Med 2021;10:4487. [PMID: 34640513 DOI: 10.3390/jcm10194487] [Reference Citation Analysis]
28 Zhang DX, Kiomourtzis T, Lam CK, Le MT. The Biology and Therapeutic Applications of Red Blood Cell Extracellular Vesicles. In: Tombak A, editor. Erythrocyte. IntechOpen; 2019. [DOI: 10.5772/intechopen.81758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
29 Fais S, Logozzi M, Alberti G, Campanella C. Exosomal Hsp60: A Tumor Biomarker? In: Asea AAA, Kaur P, editors. Heat Shock Protein 60 in Human Diseases and Disorders. Cham: Springer International Publishing; 2019. pp. 107-16. [DOI: 10.1007/978-3-030-23154-5_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Samandari M, Rafiee L, Alipanah F, Sanati-Nezhad A, Javanmard SH. A simple, low cost and reusable microfluidic gradient strategy and its application in modeling cancer invasion. Sci Rep 2021;11:10310. [PMID: 33986379 DOI: 10.1038/s41598-021-89635-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Kaczor-Urbanowicz KE, Cheng J, King JC, Sedarat A, Pandol SJ, Farrell JJ, Wong DTW, Kim Y. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers. Pancreas 2020;49:1141-52. [PMID: 33003085 DOI: 10.1097/MPA.0000000000001662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Yokose T, Kabe Y, Matsuda A, Kitago M, Matsuda S, Hirai M, Nakagawa T, Masugi Y, Hishiki T, Nakamura Y, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Nakano Y, Honda K, Kashiro A, Morizane C, Nara S, Kikuchi S, Shibahara T, Itonaga M, Ono M, Minegishi N, Koshiba S, Yamamoto M, Kuno A, Handa H, Sakamoto M, Suematsu M, Kitagawa Y. O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. Cancers (Basel) 2020;12:E2469. [PMID: 32878320 DOI: 10.3390/cancers12092469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]